Jonathan L Vennerstrom, PhD

  • 6192 Citations
  • 45 h-Index
1984 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Jonathan L Vennerstrom is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

  • Research Output

    A new chemotype with promise against Trypanosoma cruzi

    Wang, X., Cal, M., Kaiser, M., Buckner, F. S., Lepesheva, G. I., Sanford, A. G., Wallick, A. I., Davis, P. H. & Vennerstrom, J. L., Jan 1 2020, In : Bioorganic and Medicinal Chemistry Letters. 30, 1, 126778.

    Research output: Contribution to journalArticle

  • Efficacy, metabolism and pharmacokinetics of Ro 15-5458, a forgotten schistosomicidal 9-acridanone hydrazone

    Probst, A., Häberli, C., Siegel, D., Huang, J., Vigneron, S., Ta, A. P., Skinner, D. E., El-Sakkary, N., Momper, J. D., Gangoiti, J., Dong, Y., Vennerstrom, J. L., Charman, S. A., Caffrey, C. R. & Keiser, J., Oct 1 2020, In : The Journal of antimicrobial chemotherapy. 75, 10, p. 2925-2932 8 p.

    Research output: Contribution to journalArticle

  • Ligand-based design of GLUT inhibitors as potential antitumor agents

    Almahmoud, S., Jin, W., Geng, L., Wang, J., Wang, X., Vennerstrom, J. L. & Zhong, H. A., Apr 1 2020, In : Bioorganic and Medicinal Chemistry. 28, 7, 115395.

    Research output: Contribution to journalArticle

  • 1 Scopus citations

    Structure-Activity Relationship of Antischistosomal Ozonide Carboxylic Acids

    Wu, J., Wang, X., Chiu, F. C. K., Häberli, C., Shackleford, D. M., Ryan, E., Kamaraj, S., Bulbule, V. J., Wallick, A. I., Dong, Y., White, K. L., Davis, P. H., Charman, S. A., Keiser, J. & Vennerstrom, J. L., Apr 9 2020, In : Journal of Medicinal Chemistry. 63, 7, p. 3723-3736 14 p.

    Research output: Contribution to journalArticle

  • Targeted Amino Acid Substitution Overcomes Scale-Up Challenges with the Human C5a-Derived Decapeptide Immunostimulant EP67

    Alshammari, A. M., Smith, D. D., Parriott, J., Stewart, J. P., Curran, S. M., McCulloh, R. J., Barry, P. A., Iyer, S. S., Palermo, N., Phillips, J. A., Dong, Y., Ronning, D. R., Vennerstrom, J. L., Sanderson, S. D. & Vetro, J. A., May 8 2020, In : ACS infectious diseases. 6, 5, p. 1169-1181 13 p.

    Research output: Contribution to journalArticle